63PReal-life experience with the implementation of DLL3...

Annals of Oncology 2019 / 04 Vol. 30; Iss. Supplement

63PReal-life experience with the implementation of DLL3 staining and the subsequent treatment with rovalpituzumab tesirine in heavily pretreated SCLC patients

Hochmair, M J, Weinlinger, C, Fabikan, H, Koger, R, Krenbeck, D, Huemer, F, Illini, O M, Kulaksiz, M, Valipour, A, Burghuber, O C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz071.003
Date:
April, 2019
File:
PDF, 81 KB
2019
Conversion to is in progress
Conversion to is failed